|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 220.9 EGP | -0.41% |
|
-2.24% | +23.94% |
Alexandria Co. For Pharmaceuticals & Chemical Industries reported earnings results for the full year ended June 30, 2022. For the full year, the company reported revenue was EGP 1,220 million compared to EGP 1,110.54 million a year ago.
Net income was EGP 129 million compared to EGP 117 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +23.94% | 23.06M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
ALEXANDRIA CO. FOR PHARMACEUTICALS & CHEMICAL INDUSTRIES 
